| 000 | 01643 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518035046.0 | ||
| 264 | 0 | _c20200210 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1096-0384 | ||
| 024 | 7 |
_a10.1016/j.abb.2019.04.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYang, Hong | |
| 245 | 0 | 0 |
_aRole of Sirt1 in innate immune mechanisms against Mycobacterium tuberculosis via the inhibition of TAK1 activation. _h[electronic resource] |
| 260 |
_bArchives of biochemistry and biophysics _c05 2019 |
||
| 300 |
_a49-58 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 |
_aEnzyme Activation _ximmunology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Innate |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aMAP Kinase Kinase Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMacrophages, Peritoneal _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMycobacterium tuberculosis _ximmunology |
| 650 | 0 | 4 |
_aResveratrol _xpharmacology |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aSirtuin 1 _xdeficiency |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xdrug therapy |
| 700 | 1 | _aHu, Junjie | |
| 700 | 1 | _aChen, Yanghaoyu Jason | |
| 700 | 1 | _aGe, Baoxue | |
| 773 | 0 |
_tArchives of biochemistry and biophysics _gvol. 667 _gp. 49-58 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.abb.2019.04.006 _zAvailable from publisher's website |
| 999 |
_c29632370 _d29632370 |
||